Exozymes Inc (EXOZ) insider trading
Every open-market stock purchase and sale by Exozymes Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $15.4K over the last 12 months (1 sale). No open-market buys.
- Last insider buy: Michael Heltzen (CEO), $10.6K, 15 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $15.4K (1 sale). Last close $9.34 on Jun 4, 2026.
Recent EXOZ insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Apr 9, 2026 | Tyler Paz Korman (C-suite exec) | Sold | $7.9K |
| Apr 8, 2026 | Tyler Paz Korman (C-suite exec) | Sold | $7.5K |
| Apr 1, 2026 | Damien Alan Perriman (C-suite exec) | Bought (not open market) | $75K |
| Apr 1, 2026 | Fouad Nawaz (President) | Bought (not open market) | $50.6K |
| Apr 1, 2026 | Tyler Paz Korman (C-suite exec) | Bought (not open market) | $45K |
| Apr 1, 2026 | Paul Hideo Opgenorth (President) | Bought (not open market) | $33.8K |
| Apr 1, 2026 | Damien Alan Perriman (C-suite exec) | Bought (not open market) | — |
| Apr 1, 2026 | Damien Alan Perriman (C-suite exec) | Bought (not open market) | — |
Who's trading EXOZ
- Tyler Paz Korman, C-suite exec: sold $15.4K (2 sales), last Apr 9, 2026
- Fouad Nawaz, President: other filings, last Apr 1, 2026
- Paul Hideo Opgenorth, President: other filings, last Apr 1, 2026
- Damien Alan Perriman, C-suite exec: other filings, last Apr 1, 2026
Get free alerts when an insider at Exozymes Inc files a new trade →